Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin for Ureteral Stent Discomfort
NCT00467467Phase 3Completed
- Sponsor
- University of Minnesota
- Start
- Jun 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ureteral stent-related symptoms (USRS) comparing Alfuzosin with Placebo (2 arms). Primary endpoints: Effect of study medication on urinary symptoms and quality of life and Usage of analgesics/narcotics. Started Jun 2006; status: completed.
02
Drugs
alfuzosin
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on NCT00467467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467467.